Published Manuscripts
Manuscripts Submitted or in Progress
Books/Chapters
Published Abstracts
Poster Exhibits
Oral Presentations
PUBLISHED MANUSCRIPTS:
1. Buchman TG. Cabin DE. Vickers SM. Deutschman CS. Delgado E. Sussman MM. Bulkley GB. Molecular biology of circulatory shock. Part II. Expression of Four Groups of Hepatic Genes Is Enhanced after Resuscitation from Cardiogenic Shock. Surgery. 108(3):559-66, 1990 Sep.
2. Reilly PM. MacGowan S. Miyachi M. Schiller HJ. Vickers SM. Bulkley GB. Mesenteric Vasoconstriction in Cardiogenic Shock in Pigs. Gastroenterology. 102(6):1968-79, 1992 Jun.
3. Didolkar MS. Vickers SM. Perixiphoid Extension of the Midline Incision. J Am Coll Surg. 180(6):739-41, 1995 Jun.
4. Vickers SM. Phillips JO. Kerby JD. Bynon JS Jr. Thompson JA. Curiel DT. In vivo Gene Transfer to the Human Biliary Tract. Gene Ther. 3(9):825-8, 1996 Sep.
5. Vickers SM. Kerby JD. Smoot TM. Shumate CR. Halpern NB. Aldrete JS. Gleysteen JJ. Economics of Pancreatoduodenectomy in the Elderly. Surgery. 120(4):620-5, 1996 Oct.
6. Vickers SM. Rosenfeld M, Raben D, Sampson L. In Vitro Application of Molecular Chemotherapy in the Treatment of Pancreatic Cancer. Proceedings of International Hepatobiliary Assoc. Vol. 2: 1163-67, 1996.
7. Vickers SM. Sampson LK. Ying W. Phillips JO. Receptor-Dependent Growth Inhibition of Human Pancreatic Cancer by 9-cis-retinoic Acid. J Gastrointest Surg. 1(2):174-181, 1997 Mar.
8. Sampson LK. Vickers SM. Ying W. Phillips JO. Tamoxifen-Mediated Growth Inhibition of Human Cholangiocarcinoma. Cancer Res. 57(9):1743-9, 1997 May 1.
9. Rosenfeld ME. Vickers SM. Raben D. Wang M. Sampson L. Feng M. Jaffee E. Curiel DT. Pancreatic Carcinoma Cell Killing Via Adenoviral Mediated Delivery of the Herpes Simplex Virus Thymidine Kinase Gene. Ann Surg. 225(5):609-18, 1997 May.
10. Titus AS. Baron TH. Listinsky CM. Vickers SM. Solitary Breast Metastasis to the Ampulla and Distal Common Bile Duct. Am Surg. 63(6):512-5, 1997 Jun.
11. Vickers SM. Niederhuber JE. Hodgkin’s Disease Associated with Neurologic Paraneoplastic Syndrome. South Med J. 90(8):839-44, 1997 Aug.
12. Vickers SM. Sampson LS. Phillips JO. Eckhoff D. Kerby JD. Sekar MC. Curiel DT. Thompson JA. Adenoviral Vector Infection of the Human Exocrine Pancreas. Arch Surg. 132(9):1006-9, 1997 Sep.
13. Pederson LC. Buchsbaum DJ. Vickers SM. Kancharla SR. Mayo MS. Curiel DT. Stackhouse MA. Molecular chemotherapy combined with radiation therapy enhances killing of cholangiocarcinoma cells in vitro and in vivo. Cancer Res. 57(19):4325-32, 1997 Oct 1.
14. Pederson LC. Vickers SM. The surgical management of chronic pancreatitis (ductal strictures). Semin Gastrointest Dis. 9(2):80-3, 1998 Apr.
15. Vickers SM. Chan C. Heslin MJ. Aldrete JS. The role of proximal pancreatic resections in the treatment of chronic pancreatitis. Proceedings of the 3rd World Congress of the International Hepatobiliary Association, Madrid, Spain, May 24-28, 1998.
16. Pickens A. Pan G. McDonald J. Vickers SM. Tamoxifen induced apoptotic cell death utilizes the Fas/Apo-1 (CD 95) pathway in human cholangiocarcinoma. Proceedings of the 3rd World Congress of the International Hepatobiliary Association, Madrid, Spain, May 24-28, 1998.
17. Pederson LC. Vickers SM. Buchsbaum DJ. Kancharla SR. Mayo MS. Curiel DT. Stackhouse MA. Combined cytosine deaminase expression, 5-fluorocytosine exposure, and radiotherapy increases cytotoxicity to cholangiocarcinoma cells. J Gastrointest Surg. 2(3):283-91, 1998 May-Jun.
18. Vickers SM. Schiller HJ. Hildreth JE. Bulkley GB. Immunoaffinity localization of the enzyme xanthine oxidase on the outside surface of the endothelial cell plasma membrane. Surgery. 124(3):551-60, 1998 Sep.
19. Baron TH. Morgan DE. Vickers SM. Endoscopic transgastric drainage of a retroperitoneal lymphocele. Gastrointest Endosc. 48(3):309-11, 1998 Sep.
20. Vickers SM. Green M, MacMillan-Crow LA Pickens A. Thompson JA. FGF-1 Induces resistance to inflammatory-mediated Apoptosis in pancreatic cell line. Surgical Forum. 1998.
21. Baron TH. Vickers SM. Surgical gastrostomy placement as access for diagnostic and therapeutic ERCP. Gastrointest Endosc. 48(6):640-1, 1998 Dec.
22. Pedersen L. Lazenby A. Vickers SM. Abdominal actinomycosis secondary to foreign body perforation. Veterans Health System Journal. (3):41-4, 1998.
23. Pickens A. Vickers SM. Brown KL, Reddy VV. Thompson JA. An unusual etiology of biliary hilar obstruction and the potential role of acidic fibroblast growth factor in the development of a biliary neuroma. Am Surg. 65(1):47-51, 1999 Jan.
24. Titus AS. Pinckard NB. Cook WJ. Vickers SM. Solitary malignant peripheral nerve sheath tumor of the pancreas. Hepatogastroenterology. 46(25):514-7, 1999 Jan-Feb.
25. Vickers SM. MacMillan-Crow LA. Green M. Ellis C. Thompson JA. Association of increased immunostaining for inducible nitric oxide synthase and nitrotyrosine with fibroblast growth factor transformation in pancreatic cancer. Arch Surg. 134(3):245-51, 1999 Mar.
26. Pan G. Vickers SM. Pickens A. Phillips JO. Ying W. Thompson JA. Siegal GP. McDonald JM. Apoptosis and tumorigenesis in human cholangiocarcinoma cells. Involvement of Fas/APO-1 (CD95) and calmodulin. Am J Pathol. 155(1):193-203, 1999 Jul.
27. Baron TH. Morgan DE. Vickers SM. Lazenby AJ. Organized pancreatic necrosis: endoscopic, radiologic, and pathologic features of a distinct clinical entity. Pancreas. 19(1):105-8, 1999 Jul.
28. Pickens A. Pan G. McDonald JM. Vickers SM. Fas expression prevents cholangiocarcinoma tumor growth. J Gastrointest Surg. 3(4):374-82, 1999 Jul-Aug.
29. Vickers SM. Chan C. Heslin MJ. Bartolucci A. Aldrete JS. The role of pancreaticoduodenectomy in the treatment of severe chronic pancreatitis. Am Surg. 65(12):1108-11, 1999 Dec.
30. Pederson LC. Buchsbaum DJ. Stackhouse MA. Curiel DT. Mayo MS. Vickers SM. Cytosine Deaminase and herpes simplex virus Thymidine Kinase Gene Expression via adenoviral infection of human cholangiocarcinoma cells occurs in the presence of human bile. Tumor Targeting. (4):1-8, 1999.
31. Chan C. Medina-Franco H. Bell W. Lazenby A. Vickers SM. Carcinoid tumor of the hepatic duct presenting as a Klatskin tumor in an adolescent and review of world literature. Hepatogastroenterology. 47(32):519-21, 2000 Mar-Apr.
32. MacMillan-Crow LA. Greendorfer JS. Vickers SM. Thompson JA. Tyrosine nitration of c-SRC tyrosine kinase in human pancreatic ductal adenocarcinoma. Arch Biochem Biophys. 377(2):350-6, 2000 May 15.
33. Stackhouse MA. Pederson LC. Grizzle WE. Curiel DT. Gebert J. Haack K. Vickers SM. Mayo MS. Buchsbaum DJ. Fractionated radiation therapy in combination with adenoviral delivery of the cytosine deaminase gene and 5-fluorocytosine enhances cytotoxic and antitumor effects in human colorectal and cholangiocarcinoma models. Gene Ther. 7(12):1019-26, 2000 Jun.
34. Chan C. Bartolucci A. Vickers SM. Combined intraoperative alcohol celiac ablation and lateral pancreaticojejunostomy for chronic pancreatitis. Curr Surg. 57(6):636, 2000 Nov.
35. Gustin AN. Buchsbaum DJ. Kiss P. Elgavish G. Johnson M. Stackhouse M. Vickers SM. Detection of 5-FC to 5-FU via 19Fluorine NMR Spectroscopy (19F NMR) in the treatment of pancreatic cancer. Surgery. Vol. 6, 2000.
36. Alvarado CA. Vickers SM. Invited Critique: Adjuvant chemoradiotherapy for “Unfavorable” carcinoma of the ampulla vater: A Preliminary Report. Arch Surg. 136(1):69, 2001 Jan.
37. Heslin MJ. Medina-Franco H. Parker M. Vickers SM. Aldrete J. Urist MM. Colorectal hepatic metastases: resection, local ablation, and hepatic artery infusion pump are associated with prolonged survival. Arch Surg. 136(3):318-23, 2001 Mar.
38. Chan C. Vilatoba M. Bartolucci A. Vickers, SM. Improved reduction in pain in chronic pancreatitis with combined intraoperative celiac axis plexus block and lateral pancreaticojejunostomy. Curr Surg. 58(2):220-2, 2001 March.
39. Vickers SM. MacMillan-Crow L. Huang Z. Thompson JA. Acidic fibroblast growth factor (FGF-1) signaling inhibits peroxynitrite-induced cell death during pancreatic tumorigenesis. Free Radic Biol Med. 30(9):957-66, 2001 May 1.
40. Gustin A. Pederson L. Chan C. Vickers SM. The role of molecular biology in the application of gene therapy strategies. World J of Surg. 26(7):854-60, 2001 Jul.
41. Wesseling JG. Bosma PJ. Krasnykh V. Kashentseva EA. Blackwell JL. Reynolds PN. Li H. Parameshwar M. Vickers SM. Jaffee EM. Huibregtse K. Curiel DT. Dmitriev I. Improved gene transfer efficiency to primary and established human pancreatic carcinoma target cells via epidermal growth factor receptor and integrin-targeted adenoviral vectors. Gene Ther. 8(13):969-76, 2001 Jul.
42. Wesseling JG. Yamamoto M. Adachi Y. Bosma PJ. van Wijland M. Blackwell JL. Li H. Reynolds PN. Dmitriev I. Vickers SM. Huibregtse K. Curiel DT. Midkine and cyclooxygenase-2 promoters are promising for adenoviral vector gene delivery of pancreatic carcinoma. Cancer Gene Ther. 8(12):990-6, 2001 Dec.
43. Miller CR. Gustin AN. Buchsbaum DJ. Vickers SM. Manne U. Grizzle WE. Cloud GA. Diasio RB. Johnson MR. Quantitation of cytosine deaminase mRNA by real-time reverse transcription polymerase chain reaction: a sensitive method for assessing 5-fluorocytosine toxicity in vitro. Anal Biochem. 301(2):189-99, 2002 Feb.
44. Umphrey HR. Wilcox CM. Vickers SM. Extrahepatic biliary cystadenoma localized to the common bile duct. Surgery. 131(5):587-8, 2002 May.
45. Vickers SM. Jhala NC. Ahn EY. McDonald JM. Pan G. Bland KI. Tamoxifen (TMX)/Fas induced growth inhibition of human cholangiocarcinoma (HCC) by gamma interferon (IFN-gamma). Ann Surg. 235(6):872-8, 2002 June.
46. Gustin A. Pederson L. Miller R. Chan C. Vickers SM. Application of molecular biology studies to gene therapy treatment strategies. World J Surg. 26(7):854-60, 2002 Jul.
47. Vickers SM. Huang ZQ. MacMillan-Crow L. Greendorfer JS. Thompson JA. Ligand activation of alternatively spliced fibroblast growth factor receptor-1 modulates pancreatic adenocarcinoma cell malignancy. J Gastrointest Surg. 6(4):546-53, 2002 Jul-Aug.
48. Ahn EY. Pan G. Vickers SM. McDonald JM. IFN-gamma upregulates apoptosis-related molecules and enhances Fas-mediated apoptosis in human cholangiocarcinoma. Int J Cancer. 100(4):445-51, 2002 Aug.
49. Chhieng DC. Jhala D. Jhala N. Eltoum I. Chen VK. Vickers SM. Heslin MJ. Wilcox CM. Eloubeidi MA. Endoscopic ultrasound-guided fine-needle aspiration biopsy: a study of 103 cases. Cancer Cytopathology. 96(4):232-9, 2002 Aug.
50. Mohadjer Y. Danner O. Vickers SM. Methemoglobinemia induced by topical benzocaine spray for feeding tube placement. Contemporary Surgery. 58(12):22-5, 2002 Dec.
51. Shore G. Gonzalez QH. Bondora A. Vickers SM. Laparoscopic vs. conventional ileocolectomy for primary Crohn disease. Arch Surg. 138(1):76-9, 2003 Jan.
52. Nagi P. Vickers SM. Davydova J. Adachi Y. Takayama K. Barker S. Krasnykh V. Curiel DT. Yamamoto M. Development of a therapeutic adenoviral vector for cholangiocarcinoma combining tumor-restricted gene expression and infectivity-enhancement. J Gastrointest Surg. 7(3):364-71, 2003 Mar-Apr.
53. Melton SM. McGwin G Jr. Cross JM. Davidson J. Waller H. Doss MW. Vickers SM. Rue LW 3rd. Common bile duct transection in blunt abdominal trauma: case report emphasizing mechanism of injury and therapeutic management. J Trauma. 54(4):781-5, 2003 Apr.
54. Huang, ZQ. Buchsbaum DJ. Raisch KP. Bonner JA. Bland KI. Vickers SM. Differential responses by pancreatic carcinoma cell lines to prolonged exposure to Erbitux (IMC-C225) anti-EGFR antibody. J Surg Res. 111(2):274-83, 2003 May.
55. Gonzalez QH. Heslin MJ. Shore G. Vickers SM. Urist MM. Bland KI. Results of long-term follow-up for trans-anal excision of rectal cancer. Am Surg. 69(8):675-8, 2003 Aug.
56. Yamamoto M. Davydova J. Wang M. Siegal GP. Krasnykh V. Vickers SM. Curiel DT. Infectivity enhanced, Cyclooxygenase-2 Promoter-Based Conditionally Replicative Adenovirus for Pancreatic Cancer. Gastroenterology. 125(4):1203-18. 2003 Oct.
57. Eloubeidi MA. Jhala D. Chhieng DC. Chen VK. Eltoum I. Vickers SM. Wilcox CM. Jhala N. Yield of endoscopic ultrasound-guided fine-needle aspiration biopsy in patients with suspected pancreatic carcinoma. Cancer. 99(5):285-92, 2003 Oct.
58. Eloubeidi MA. Iseman DT. Chen VK. Vickers SM. Wilcox CM. Prevalence and significance of periduodenal venous collaterals in patients evaluated for pancreaticobiliary disorders by endosonography. Endoscopy. 35(12):1015-9, 2003 Dec.
59. Eloubeidi MA. Chen VK. Eltoum IE. Jhala D. Chhieng DC, Jhala N. Vickers SM. Wilcox CM. Endoscopic Ultrasound-Guided Fine Needle Aspiration Biopsy of Patients with Suspected Pancreatic Cancer: Diagnostic Accuracy and Acute and 30-Day Complications. Am J Gastroenterol. 98(12):2663-8, 2003 Dec.
60. Eloubeidi MA. Chen VK. Volk AL. Jhala N. Vickers SM. Chhieng D. Recurrent metastatic Klatskin’s carcinoid tumor to celiac lymph nodes in a teenager: diagnosis by endoscopic ultrasound-guided fine needle aspiration biopsy with immunocytochemical correlation. Dig Dis Sci. 48(12):2301-5, 2003 Dec.
61. Saif MW. Joseph M. Tang S. Vickers SM. Plants B. Russo S. Retrospective Analysis of Capecitabine and Radiation Therapy in the Treatment of Pancreatic Cancer. J of App Research. 4(4):635-646, 2004.
62. Hawn MT. Canon CL. Lockhart ME. Gonzalez QH. Shore G. Bondora A. Vickers SM. Serum Lactic Acid Determines the Outcomes of CT Diagnosis of Pneumatosis of the Gastrointestinal Tract. Am Surg. 70(1):19-24, 2004 Jan.
63. Ramirez PJ. Vickers SM. Current Status of Gene Therapy for Pancreatic Cancer. Curr Surg. 61(1):84-92, 2004 Jan-Feb.
64. Eloubeidi MA. Chen VK. Jhala NC. Eltoum IE. Jhala D. Chhieng DC, Syed SA. Vickers SM. Wilcox MC. Endoscopic ultrasound-guided fine needle aspiration biopsy of suspected cholangiocarcinoma. Clin Gastroenterol Hepatol. 2(3):209-13, 2004 March.
65. Wan M. Tang Y. Tytler EM. Lu C. Jin B. Vickers SM. Yang L. Shi X. Cao X. Smad4 protein stability is regulated by ubiquitin ligase SCF beta-TrCP1. J Biol Chem. 279(15):14484-7, 2004 April.
66. Gonzalez QH. Tishler DS. Plata-Munoz JJ. Bondora A. Vickers SM. Leath T. Clements RH. Incidence of Clinically Evident Deep Venous Thrombosis after Laparoscopic Roux-en-Y Gastric Bypass. Surg Endosc. 18(7):1082-4, 2004 July.
67. Ramirez PJ. Vickers SM. Adenoviral Gene Therapy for Pancreatic Adenocarcinoma. Curr Surg. 61(4):351-8, 2004 July/August.
68. Jhala NC. Jhala D. Eltoum I. Vickers SM. Wilcox M. Chhieng DC. Eloubeidi MA. Endoscopic ultrasound guided fine needle aspiration: A powerful tool to obtain samples from small lesions. Cancer Cytopathology. 102(4):239-46, 2004 Aug.
69. Ramirez PJ. Vickers SM. Regulatory Cells. Curr Surg. 61(5):407-10, 2004 Sept-Oct.
70. Arnoletti JP. Buchsbaum DJ. Huang Z. Hawkins, AE. Kraus MH. Vickers SM. Mechanisms of Resistance to Erbitux (Anti-Epidermal Growth Factor Receptor) Combination Therapy in Pancreatic Adenocarcinoma Cells. J Gastrointest Surg. 8(8):960-9, 2004 Dec.
71. Jhala N. Vickers SM. Argani P. McDonald J. Regulators of Apoptosis in Cholangiocarcinoma. Arch Pathology & Laboratory Med. 129(4):481-6, 2005 April.
72. Hawn MT. Bian J. Leeth RR. Ritchie G. Allen N. Bland KI. Vickers SM. Impact of Obesity on Resource Utilization for General Surgical Procedures. Annals of Surgery. 241(5):821-6, 2005 May.
73. Wan M. Huang J. Jhala NC. Tytler EM. Yang L. Vickers SM. Tang Y. Lu C. Wang N. Cao X. SCFβ-TrCP1 controls Smad4 protein stability in pancreatic cancer cells. Am J Pathol. 166(5):1379-92, 2005 May.
74. Tekant Y. Davydova J. Ramirez PJ. et al. Oncolytic Adenoviral Therapy in Gallbladder Cancer. Surgery. 137:327-35, 2005 May.
75. Tempero MA. Behrman S. Ben-Josef E. Benson AB 3rd. Cameron JL. Casper ES. Hoffman JP. Karl RC. Kim P. Koh WJ. Kuvshinoff BW 2nd. Melvin WS. Muscarella P 2nd. Sasson AR. Shibata S. Shrieve DC. Talamonti MS. Tyler DS. Vickers SM. Warren RS. Willett C. Wolff RA; National Comprehensive Cancer Network. Pancreatic Adenocarcinoma: Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 3(5):598-626, 2005 Sept.
76. Eltoum IA. Eloubeidi MA. Chhient DC. Tamhane A. Crowe R. Jhala D. St. John KD. Wilcox CM. Siegal GP. Vickers SM. Jhala NC. Cytologic Grade Independently Predicts Survival of Patients with Pancreatic Adenocarcinoma. Am J Clin Pathol. 124(5):697-707, 2005 Nov.
77. Katasani VG. Leeth RR. Tishler DS. Leath, TD. Roy, BP. Canon CL. Vickers SM. Clements RH. Water-Soluble Upper GI Based on Clinical Findings Is Reliable to Detect Anastomotic Leaks After Laparoscopic Gastric Bypass. Am Surg. 71(11):916-8, 2005 Nov.
78. Finan KR. Leeth RR. Ritchie G. Vickers SM. Hawn MT. Obesity Status and Utilization of General Surgery Resources. Am Surg. 71(11):963-9, 2005 Nov.
79. Blanquicett C. Buchsbaum DJ. Saif MW. Eloubeidi M. Vickers SM. Chhieng DC. Carpenter MD. Sellers JC. Russo S. Diasio RB. Johnson MR. Antitumor Efficacy of Capecitabine and Celecoxib in Irradiated and Lead Shielded, Contralateral Human BxPC-3 Pancreatic Cancer Xenografts: Clinical Implications of Abscopal Effects in a Metastatic Model. Clinical Cancer Research. 11(24):8773-81, 2005 Dec.
80. Steg A. Wang W. Blanquicett C. Grunda JM. Eltoum IA. Wang K. Buchsbaum DJ. Vickers SM. Russo S. Diasio RB. Frost AR. LoBuglio AF. Grizzle WE. Johnson MR. Multiple Gene Expression Analyses in Paraffin-Embedded Tissues by Taqman Low Density Array: Application to Hedgehog and Wnt Pathway Analysis in Ovarian Endometrioid Adenocarcinoma. Journal of Molecular Diagnostics. 8(1):76-83, 2006 Feb.
81. Allen NC. Leeth RR. Finan KR. Tischler DS. Vickers SM. Wilcox CM. Hawn MT. Outcomes of Cholecystectomy Following Endoscopic Sphincterotomy for Choledocholithiasis. J Gastrointest Surgery. 10(2):292-6, 2006 Feb.
Top of page
MANUSCRIPTS SUBMITTED OR IN PROGRESS:
1. Jhala N. Pan G. Ahn EY. Talley L. Vickers SM. McDonald JM. Modulation of Fas (CD95/APO-1) and its ligand: a potential target for the treatment of cholangiocarcinoma. Submitted to Lab Investigation. 2002 Nov.
2. Gonzalez Q. Shore G. Bondora A. Vickers SM. Postoperative Complications and Functional Results After Total Proctocolectomy for Ulcerative Colitis. Are there differences among, one, two or three stages operation? Submitted to Int J Colorectal Surg. 2003 Feb.
3. Gonzalez QH. Heslin MJ. Davila-Cervantes A. Alvarez-Tostado J. De Los Monteros AE. Shore G. Vickers SM. Primary Colonic Lymphoma. Submitted to Am Surg. 2003 Feb.
4. Chan C. Arch-Ferrer JE. Aldrete JS. Podgaetz E. Vickers SM. Effectiveness of Lateral Pancreaticojejunostomy to Relieve Pain in Patients with Chronic Fibrous Pancreatitis. Submitted to J Gastrointest Surg. 2003 Mar.
5. Kiss P. Gustin A. Buchsbaum DJ. Simor T. Lenard, Jr L. Miller R. Vickers SM. Elgavish GA. 19Fluorine NMR spectroscopic evaluation of the efficiency of cytosine deaminase gene transfer in the treatment of colon cancer. Submitted to Cancer Investigation. 2003 September.
6. Ramirez PJ. Ono HA. Davydova J. Krasnykh V. Takayama K. Timme TL. Curiel DT. Yamamoto M. Vickers SM. Optimization of Conditionally Replicative Adenovirus for Pancreatic Cancer. Submitted to J Surg Res. 2003 Nov.
7. Sarr M. Traverso W. Castillo C. Aranha G. Evans D. Gibbs J. Gillanders W. Conlon K. Michelassi F. Mulholland M. Murr M. Nealon W. Pappas T. Prinz R. Shamamian P. Vickers SM. Weaver S. Wilson S. Ahrendt S. Zinner M. The potent somatostatin analogue vapreotide does not decrease pancreas-specific complications after elective pancreatectomy: a prospective multi-center, double-blinded, randomized, placebo-controlled trial. In Press. J Am Coll Surg.
8. Eloubeidi MA. Desmond RA. Wilcox CM. Wilson RJ. Manchikalapati P. Fouad MM. Eltoum I. Vickers SM. Prognostic Factors for Survival in Pancreatic Cancer: A Population-Based Study. In Press. Am J Surgery.
Top of page
BOOKS/CHAPTERS:
1. Vickers SM, Bailey RW, Bulkley GB: Ischemic hepatitis in: Marston A, Bulkley GB, Fiddian-Green RG, Haglund UH (eds), Splanchnic Ischemia and Multiple Organ Failure pp 261-267, London, Edward Arnold, Ltd., 1989.
2. Pederson LC and Vickers SM. A Clinical Approach to Proximal Hilar Cholangiocarcinoma and Gallbladder Carcinoma. Van Leeuwen D (ed) Cholangiocarcinoma, Pathogenesis and Diagnosis, (Book Chapter) 1998.
3. Vickers SM. Surgery of the Pancreas, 2nd Edition. Trede M and Carter DC (eds). New York, Churchill Livingstone, 1997. Book Review Archives of Surgery. 133: 909-910, 1998.
4. Vickers SM. Pancreatic Cancer: Pathogenesis Diagnosis and Treatment, 1st Edition. Reber #A, Totawa, NJ, Humana Press, 1998. Book Review Archives of Surgery. 133:1367-1368, 1998.
5. Vickers SM. Nagi PA. Nutritional Requirements Following Cancer Treatment/Surgery. Handbook of Clinical Nutrition and Aging. Totawa, NJ, Humana Press. Chapter 20;477-86. 2004.
6. Smith MD. Degiannis E. Vickers SM. Surgery for Chronic Pancreatitis. Pancreatitis and Complications. Totawa, NJ, Humana Press. (Book Chapter) submitted 2003.
7. Vickers SM, Arnoletti JP: Pancreas Anatomy and Physiology. Greenfield LJ, Mulholland MW, Oldham KT, Zelenock GB, Lillemoe KD (eds), Surgery: Scientific Principles and Practice, 4th Edition (Book Chapter) (in press).
Top of page
PUBLISHED ABSTRACTS:
1. Qadir M, Sussman MS, Vickers S, Im MJ, Manson PM, Engler RL, Bulkley GB. Mechanism of enhanced skin flap survival by xanthine oxidase inhibition: purine salvage or ablation of free radical generation (Abstract).
2. Buchman TG, Cabin DE, Vickers S, Bulkley GB. Cardiogenic (tamponade) and resuscitation increases hepatic expression of two serine protease inhibitors mRNAs. Gastroenterology. 96:A580, 1989.
3. Bailey RW, Vickers S, Porter JM, Meilahn JE, Morris JB, Sussman MS, Buchman TG, Haglund UH, Hami SR, Herlong HF, Tang WS, Bulkley GB. The development of multiple organ system failure in swine following splanchnic ischemia in response to cardiogenic shock. Gastroenterology. 96:A23, 1989.
4. Deutschman CS, Cabin DE, Delgado EM, Vickers S, Bulkley GB, Buchman TG. Differential complimentary DNA (cDNA) screening identifies induction of fibrinogen gene expression following shock/resuscitation. Anesthesiology 10:1989.
5. Vickers S, Miyachi M, Hildreth J, Baig M, Kuhajda F, Madara P, Mather I,Bulkley GB. Immunohistoaffinity localization of xanthine oxidoreductase (XOR) and histochemical discrimination of dehydrogenase (XD) from oxidase (XO) in situ. FASEB Journal 4:A896, 1990.
6. Miyachi M, Vickers S, Bulkley GB. Quantitative histochemical localization of xanthine oxidoreductase (XOR) with discrimination of the dehydrogenase (XD) from the oxidase (XO) forms in tissue sections. Circ Shock 31:80, 1990.
7. Vickers S, Hildreth J, Kuhajda F, Madara P, Mather I, Baig M, Bulkley GB. Immunohistoaffinity localization of the xanthine oxidase in the microvascular endothelial cells of porcine and human organs. Circ Shock 31:87, 1990.
8. Schiller HJ, Vickers S, Hildreth J, Mather I, Kahajda, Bulkley GB. Immunoaffinity localization of xanthine oxidase on the outside surface of the endothelial cell plasma membrane. Circ Shock 34:A435, 1991. (Resident’s Award Winner, Shock Society, 1991).
9. Miyachi M, Vickers S, Schiller HJ, Patel P, Mather I, Hildreth J, Kuhajda F, Bulkley GB. Immunoaffinity localization of the free radical-generating enzyme xanthine oxidase in the microvascular endothelium of the porcine and human brain. Circ Shock 34:A436, 1991.
10. Vickers SM, Chan C, Heslin MJ and Aldrete JS. The Role of Pancreaticoduodenectomy in the Treatment of Severe Chronic Pancreatitis. (Abstract)
11. Pederson LC, Buchsbaum DJ, Stackhouse, MA, Curiel DT and Vickers SM. Effective Toxin Gene Expression Via Adenoviral Infection of Human Cholangiocarcinoma Cells in the Presence of Human Bile. (Abstract)
12. Pickens A, Pan G, McDonald J and Vickers SM. Involvement of FAS in Tamoxifen-Induced Apoptosis of Cholangiocarcinoma. (SSAT 1997)
13. Pederson LC, Vickers SM, Buchsbaum DJ. Kancharla SR. Mayo MS. Curiel DT. Stackhouse MA, Curiel DT, Mayo MS, Kancharla S, Bright S, Olsen C, Buchsbaum DJ. Cytosine Deaminase Gene Therapy and Fractionated Radiation Therapy Enhances Anti-Tumor Effects in Human Cholangiocarcinoma. (SSAT 1997)
14. Vickers SM, Phillips JO, Eckhoff D, Kerby JD, Thompson J and Curiel DT. Gene Transfer of a Recombinant Adenoviral Vector to the Human Biliary Tract. (Abstract)
15. Vickers SM, Pederson LC, Stackhouse MA, Douglas JT, Sosnowski B, Curiel DT and Buchsbaum DJ. Redirection of adenoviral mediated cytosine deaminase gene transfer via FGF2 receptor enhances pancreatic carcinoma and cholangiocarcinoma cytotoxicity to 5-fluorocytosine conversions to 5-fluorouracil. (Abstract)
16. Gustin AN, Buchsbaum DJ, Kiss P, Elgavish G, Johnson M, Stackhouse M, Vickers SM: Detection of 5-FC to 5-FU conversion by cytosine deaminase via 19Fluorine NMR spectroscopy (19F NMR) in the treatment of pancreatic cancer. The Society of University Surgeons 61st Annual Meeting, Toronto, Canada, February 10-12, 2000.
17. Vickers SM, MacMillan-Crow LA, Green M, Thompson JA. Alternatively Spliced FGFR-1 Isoforms Atenuate the Malignant Phenotype of FGF-1 Transformed Pancreatic Ductal Cells. (Abstract)
18. Blanquicett C. Buchsbaum DJ. Vickers SM. Sellers J. Carpenter M. Diasio RB. Johnson MR. Rationale for capecitabine and radiation (XRT) or cyclooxygenase-2 (COX-2) inhibitors to treat pancreatic cancer. (Abstract) Submitted to American Society of Clinical Oncology Meeting.
19. Blanquicett C. Buchsbaum DJ. Vickers SM. Sellers J. Chhieng C. Carpenter M. Diasio RB. Johnson R. Utilizing a Pharmacogenomic Approach to Design Treatment Paradigms for Pancreatic Cancer. (Abstract)
20. Jhala NC. Tytler E. Vickers SM. Oeschlenger D. Grizzle WE. Heterogenous Protein Expression Pattern in Human Pancreatic Cancer Cells: Analysis by Novel Protein Chip Technology (SELDI-TOFM). Poster accepted Lab Invest and Modern Path. 2003, Jan.
21. Vickers, SM. Gonzalez QH. Gomez F. Bondora A. Necrosectomy Through Cyst-Gastrostomy for the Treatment of Pancreatic Necrosis. (Abstract) Submitted to the Society of Black Academic Surgeons Scientific Seminar, 2003 April.
22. Eloubeidi MA. Chen VK. Jhala NN. Eltoum IE. Jhala D. Chhieng DC. Syed SA. Vickers SM. Wilcox CM. Endoscopic Ultrasound Guided Fine Needle Aspiration Biopsy in Patients with Suspected Cholangiocarcinoma: Diagnostic Accuracy and Impact on Management. (Abstract) Submitted to Digestive Disease Week Conference, 2003, May.
23. Sarr M. Traverso W. Castillo C. Aranha G. Evans D. Gibbs J. Gillanders W. Conlon K. Michelassi F. Mulholland M. Murr M. Nealon W. Pappas T. Prinz R. Shamamian P. Vickers S. Weaver s. Wilson S. Ahrendt S. Zinner M. Vapreotide, A Potent Long-Acting Somatostatin Analogue, Does Not Decrease Pancrease-Related Complications After Elective Pancreatectomy—A Multicenter, Double-Blind, Randomized Placebo-Controlled Study. Submitted to the American College of Surgeons Clinical Congress, San Francisco, October 6-10, 2002. Accepted for presentation.
Top of page
POSTER EXHIBITS:
1. Gonzalez QH. Plata-Munoz JJ. Bondora A. Vickers SM. Clements, RH. Incidence of Deep Venous Thrombosis (DVT) in Patients Undergoing Laparoscopic Roux-en-Y Gastric Bypass. Accepted for Poster Presentation. 2003 Society for American Gastrointestinal Endoscopic Surgeons (SAGES) Scientific Session and Postgraduate Courses. 2003 Mar.
2. Clements RH. Gonzalez QH. Leath T. Vickers SM. Gastrointestinal Symptoms are More Severe in Preoperative Morbidly Obese Patients. Accepted for Poster Presentation. 2003 Society for American Gastrointestinal Endoscopic Surgeons (SAGES) Scientific Session and Postgraduate Courses. 2003 Mar.
3. Christein JD. Leeth RR. Murthy RK. Heslin M. Jhala NC. Arnoletti JP. Vickers SM. Biological Markers as Predictors of Outcome and Margin Status for Pancreatic Adenocarcinoma after Pancreaticoduodenectomy. Accepted for Poster Presentation. 2006 Congress of the American Hepato-Pancreato-Biliary Association. 2006 Mar.
Top of page
ORAL PRESENTATIONS:
1. Baltimore Academy of Surgery, Resident Research Award presentation, “Roeulyution of Xanthine Oxidase in the Human Heart”, 1989.
2. Society of University Surgeons, “Localization of Xanthine Oxidase on the Outer Surface of Endothelial Cells”, 1991.
3. Alabama Chapter of the American College of Surgery, “Pancreatoduodenectomies in the Elderly”, 1994.
4. Society for Surgery of the Alimentary Tract, “The Role of Retinoic Acid in the Treatment of Pancreatic Cancer”, 1995.
5. Southern Surgical Association, “Adenoviral HSV-TK Killing of Pancreatic Cancer”, 1995 (discussant).
6. Central Surgical Association, “Pancreatoduodenectomy in the Elderly”, 1995.
7. Society of Surgery of the Alimentary Tract, “Retinoic Acid Inhibition of Pancreatic Cancer”, 1995.
8. Alabama Chapter of the American College of Surgery, “Molecular Chemotherapy for the Treatment of Pancreatic Cancer”, 1995.
9. Society of Black Academic Surgeons, “Gene Therapy for Pancreatic Cancer”, 1995.
10. Grand Rounds, Vanderbilt Department of Surgery, “The Role of FGF in Pancreatic Cancer”, 1996.
11. VA Surgeons Association, “The Role of FGF-1 in Pancreatic Cancer”, 1997.
12. Visiting Professor - Medical College of Georgia, “Gene Therapy for Pancreatic Cancer”, 1998.
13. Visiting Professor – Mexican Gastroenternal Society – Torreon, Mexico, “Gene Therapy for the Treatment of Pancreatic Cancer”, 1998.
14. Visiting Professor – Mexican College of Surgeons, “The Role of Pancreatico-duodenectomy in the Treatment of Chronic Pancreatitis” – Leon, Mexico, 1998.
15. American College of Surgeons (Surgical Forum), “FGF-1 Produces Resistance to Inflammatory Mediated Apoptosis”, 1998.
16. Molecular Surgeon – Baylor College of Medicine – “Overexpression of FGF-1, FGF-2 and FGFR1-2 in Pancreatic Cancer: Implications for Treatment”- Houston, TX, 1999.
17. Mercer University – Update in the Current Treatment of Pancreatic Cancer.
18. Meharry Medical/Vanderbilt – March 2003 New Paradigm for Treatment of Cholangiocarcinoma.
19. Society for Surgery of the Alimentary Tract, “Mechanisms of Resistance to Erbitux (Anti-Epidermal Growth Factor Receptor) Combination Therapy in Pancreatic Adenocarcinoma Cells”, 2004.
Top of page
Return to Faculty Page